Potassium Ion

Potassium Ion

SCHEMBL7190441

Cc1cc(=O)c(C(=O)[O-])nn1-c1ccc(F)c(Cl)c1.[K+]

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 13/20 0.51
ALDH1A1 P00352 2/20 0.47
MAPK1 P28482 1/20 0.47
POLB P06746 2/20 0.45
BRD9 Q9H8M2 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Potassium Ion SCHEMBL2691671 0.86 RIPK1 (0.59) RIPK1MAPK1
SCHEMBL10812826 0.83 RIPK1 (0.59) RIPK1MAPK1
SCHEMBL9183007 0.76 MAPK1 (0.68) RIPK1ALDH1A1MAPK1POLBL3MBTL1
SCHEMBL4499756 0.74 L3MBTL1 (0.60) ALDH1A1POLBL3MBTL1
SCHEMBL17055469 0.74 L3MBTL1 (0.56) ALDH1A1MAPK1POLBBRD9L3MBTL1
SCHEMBL17055466 0.72 MALT1 (0.53) ALDH1A1MAPK1POLBBRD9L3MBTL1
SCHEMBL122207 0.72 MAPK1 (0.76) RIPK1MAPK1POLB
SCHEMBL10756366 0.72 RIPK1 (0.61) RIPK1ALDH1A1MAPK1POLB
SCHEMBL10761439 0.71 RIPK1 (0.60) RIPK1MAPK1
SCHEMBL10812821 0.71 MAPK1 (0.74) RIPK1MAPK1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030192070-A1 COMPOSITION FOR HYBRID SEED PRODUCTION, PROCESS FOR THE PREPARATION OF SUCH COMPOSITION AND USE THEREOF COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2003-10-09 US claimed
US-6645917-B2 Mixture of potassium 1-(4-chlorophenyl)- and 1-(4-fluoro-3-chlorophenyl)-1,4 dihydro-6-methyl-4-oxopyridazine-3-carboxylate and nonionic surfactant; enhances male sterility; wheat, cereals COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2003-11-11 US disclosed
US-6645917-B2 Mixture of potassium 1-(4-chlorophenyl)- and 1-(4-fluoro-3-chlorophenyl)-1,4 dihydro-6-methyl-4-oxopyridazine-3-carboxylate and nonionic surfactant; enhances male sterility; wheat, cereals COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2003-11-11 US disclosed
US-20030192070-A1 COMPOSITION FOR HYBRID SEED PRODUCTION, PROCESS FOR THE PREPARATION OF SUCH COMPOSITION AND USE THEREOF COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2003-10-09 US disclosed
US-20030192070-A1 COMPOSITION FOR HYBRID SEED PRODUCTION, PROCESS FOR THE PREPARATION OF SUCH COMPOSITION AND USE THEREOF COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2003-10-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030192070-A1 COMPOSITION FOR HYBRID SEED PRODUCTION, PROCESS FOR THE PREPARATION OF SUCH COMPOSITION AND USE THEREOF ZP1, KCNK4, NASP RIPK1 3482/4885ALDH1A1 1593/4885MAPK1 2808/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.